TNF and myeloid sarcoma: The differential roles of TNF in MS are mediated by multiple pathways, therefore addressing a possible shift of the balance between TNF-R1 and TNF-R2 signalling in the pathological condition could be an important avenue for MS treatment, but further studies are necessary.